Expression of vascular endothelial growth factor (VEGF) and its two receptors in diffusely infiltrating astrocytomas and relationship to proliferative activity of tumor cells.

被引：13

作者：

Xiang F. ^{[1
]}

Tanaka J. ^{[1
]}

Takahashi J. ^{[1
]}

Fukuda T. ^{[1
]}

机构：

[1] Department of Pathology, Medical College of Qingdao University

来源：

Brain Tumor Pathology | 2001年 / 18卷 / 2期

关键词：

Vascular endothelial growth factor; Vascular endothelial growth factor receptors; Flk1; Flt1; MIB-1; Astrocytic tumor;

D O I：

10.1007/BF02479418

中图分类号：

学科分类号：

摘要：

We studied the relationships among vascular endothelial growth factor (VEGF), its receptors (Flt1 and Flk1), and MIB-1. Their expression in 47 diffusely infiltrating astrocytomas obtained at surgery or autopsy was investigated by the ABC method and analyzed quantitatively. The positive rate of VEGF in tumor cells was higher than that in endothelial cells, and Flk1 was lower in tumor cells (P < 0.01, 0.01), whereas Flt1 in both tumor cells and endothelial cells was found at similar levels (P > 0.05). In tumor cells, VEGF became high with increased histological grades (P < 0.01). whereas both Flt1 and Flk1 were higher in grade 4 than in grades 2 and 3 (P < 0.01, 0.05). VEGF, Flt1, and Flk1 in endothelial cells were also highly expressed in grade 4 (P < 0.01). The distribution of MIB-1-positive nuclei in grade 4 was similar to VEGF, and the percent of positivity from grade 2 to grade 4 also increased (P < 0.01). There was a linear positive correlation between VEGF and both Flt1 and Flk1 in both tumor cells and endothelial cells (P < 0.01). So was the percent of positivity with VEGF, Flt1, and Flk1 in tumor cells and endothelial cells (P < 0.01). The experiment suggests that VEGF may act as a growth factor for both endothelial cells and tumor cells. VEGF, Flt1, and Flk1 can be considered as indicators of the malignancy potential of diffusely infiltrating astrocytomas. The expression of VEGF and the two receptors may be affected by the proliferative activity of tumor cells.

引用

页码：67 / 71

页数：4

共 56 条

[1]

Folkman J(1995)Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Med 1 27-31

[2]

Folkman J(1987)Angiogenic factors Science 235 442-447

[3]

Klagsbrun M(1992)Platelet-derived growth factor receptor is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas Lab Invest 67 529-534

[4]

Plate KH(1994)Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery 35 439-449

[5]

Brier G(1992)Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo Nature (Lond) 359 845-848

[6]

Farrell CL(1995)Vascular permeability factor/vascular endothelial growth, microvascular hyper-permeability, and angiogenesis: review Am Med J 146 1029-1039

[7]

Weindel K(1993)Vascular endothelial growth factor Trends Cardiovasc Med 3 244-250

[8]

Moringlane JR(1993)Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 362 841-844

[9]

Marme D(1994)Vascular endothelial growth factor and glioma: angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms Int J Cancer 59 520-529

[10]

Plate KH(1998)Expression of vascular endothelial growth factor and its receptors in anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma Am J Surg Pathol 22 816-826

← 1 2 3 4 5 6 →